Market Access/ News/ News Flash FDA approval sends ChemoCentryx spiralling upwards Phil Taylor autoimmune disease, avacopan, ChemoCentryx, fda, rare disease, regulatory approval, Tavneos 0 Comment ChemoCentryx has claimed FDA approval for its avacopan drug for a rare autoimmune disease, becoming the first orally-active Share X Flash FDA approval sends ChemoCentryx spiralling upwards https://pharmaphorum.com/news/flash-fda-approval-sends-chemocentryx-spiralling-upwards/